Biogen (BIIB)

Operating Expenses

$1.24B

Quarterly · Period ending: · USD

BIIB logo

BIIB Operating Expenses

Latest reported$1.24B
BIIB Quarterly Operating Expenses ($4.00M → $1.24B)
High-resolution chart · PNG

BIIB operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
1,239,300,000
1,419,400,000
1,840,000,000
964,400,000
1,111,200,000
1,120,500,000
1,362,200,000
1,249,900,000
1,142,600,000
1,102,000,000
1,255,600,000
1,549,900,000
1,173,600,000
1,225,800,000
1,414,800,000
1,169,000,000
1,168,700,000
1,253,500,000
1,566,800,000
1,467,500,000
1,844,500,000
1,242,000,000
2,692,600,000
1,840,600,000
1,296,000,000
1,260,100,000
1,446,500,000
1,363,800,000
1,184,500,000
1,385,100,000
1,594,700,000
1,280,600,000
1,722,300,000
1,150,400,000
1,331,600,000
1,053,900,000
1,511,200,000
1,401,400,000
1,659,700,000
1,113,600,000
1,063,400,000
1,035,400,000
1,339,300,000
1,096,100,000
1,072,400,000
1,124,600,000
1,183,673,000
1,056,229,000
1,140,840,000
1,179,158,000
1,049,371,000
908,553,000
835,135,000
781,890,000
849,145,000
713,952,000
776,116,000
789,447,000
777,970,000
431,443,000
697,331,000
683,946,000
763,582,000
885,736,000
709,837,000
708,116,000
643,978,000
642,854,000
779,654,000
633,329,000
642,792,000
639,621,000
604,246,000
595,248,000
543,304,000
578,408,000
482,673,000
452,268,000
-356,344,000
439,372,000
704,063,000
370,692,000
-282,679,000
485,485,000
488,240,000
412,919,000
-169,244,000
407,983,000
388,504,000
370,840,000
654,898,000
66,490,000
76,627,000
53,252,000
177,599,000
177,197,000
180,915,000
155,857,000
151,790,000
139,148,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.